Back to User profile » Dr Yongkang Xu

Papers published by Dr Yongkang Xu:

Original Research

Lenvatinib Plus PD-1 Inhibitors versus Regorafenib in Patients with Advanced Hepatocellular Carcinoma After the Failure of Sorafenib: A Retrospective Study

Xu Y, Fu S, Liu K, Mao Y, Wu J

Therapeutics and Clinical Risk Management 2023, 19:853-863

Published Date: 24 October 2023

Original Research

Efficacy and Safety of Regorafenib with or without PD-1 Inhibitors as Second-Line Therapy for Advanced Hepatocellular Carcinoma in Real-World Clinical Practice

Liu K, Wu J, Xu Y, Li D, Huang S, Mao Y

OncoTargets and Therapy 2022, 15:1079-1094

Published Date: 1 October 2022